Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer.
about
Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancerAmifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancerAmifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancerRadioiodine Remnant Ablation: A Critical ReviewThe impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study.A Phase 1, Multi-Center, Open-Label, Dose-Escalation Study of 131I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid Malignancies.Differentiated Thyroid Cancer-Treatment: State of the Art.Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCiPrognostic factors of a good response to initial therapy in children and adolescents with differentiated thyroid cancerAcute severe hypothyroidism is not associated with hyponatremia even with increased water intake: a prospective study in thyroid cancer patients.Recombinant TSH stimulated remnant ablation therapy in thyroid cancer: the success rate depends on the definition of ablation success--an observational study.Low versus high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a meta-analysis of randomized controlled trials.Difference between papillary and follicular thyroid carcinoma outcomes: an experience from Egyptian institution.Analysis of clinical outcome of patients with poorly differentiated thyroid carcinoma.Use of radioactive iodine for thyroid cancer.The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.Strong Neck Accumulation of 131I Is a Predictor of Incomplete Low-Dose Radioiodine Remnant Ablation Using Recombinant Human Thyroid-Stimulating Hormone.Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years.Antithyroglobulin Antibody as a Marker of Successful Ablation Therapy in Differentiated Thyroid Cancer.To treat or not to treat: the role of adjuvant radioiodine therapy in thyroid cancer patients.Neurological deficit as a presentation of occult metastatic thyroid carcinoma.Differentiated thyroid cancer: feasibility of loboisthmectomy in an endemic region.The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.Expression of Notch 1 receptor associated with tumor aggressiveness in papillary thyroid carcinoma.Papillary thyroid microcarcinomas: big decisions for a small tumorAssociation between excessive urinary iodine excretion and failure of radioactive iodine thyroid ablation in patients with papillary thyroid cancer.Molecular genetics of papillary thyroid carcinoma: great expectations.A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors.I-131 for Remnant Ablation in Differentiated Thyroid Cancer After Thyroidectomy: A Meta-Analysis of Randomized Controlled Evidence.Is routine central neck dissection necessary for the treatment of papillary thyroid microcarcinoma?Remnant uptake as a postoperative oncologic quality indicatorNew developments in the diagnosis and treatment of thyroid cancer.BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer.Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer.Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer.Radioiodine for remnant ablation and therapy of metastatic disease.Well differentiated thyroid carcinoma: current treatment.Predictive value of metastatic cervical lymph node ratio in papillary thyroid carcinoma recurrence.High versus low radioiodine activity in patients with differentiated thyroid cancer: a meta-analysis.Differentiated thyroid cancer-personalized therapies to prevent overtreatment.
P2860
Q24236576-F712E44B-8440-49E5-95E7-B4AC2DF521A7Q24240279-E4ACA0EA-9548-4319-B31E-FC51F3022FEDQ24240711-D47583B0-A531-4A9E-A930-4914778EA13BQ26784202-2260D599-608E-4234-B48C-4E1F7BC3EE54Q33399709-58CE5FB9-ECCB-47D0-966D-A1780E287D37Q33427321-B951EE9F-6656-4D3D-A0C5-F0DE5D8EED3FQ33839037-E452C960-B360-41EE-851B-C6C9E367A6CDQ34341331-1600C195-872E-40C0-80B4-1C5EAD98DC35Q34691509-EFC4CFB1-5912-4A38-A5AD-6CC7FED6A5ECQ34884644-3824C575-1ACB-4B7D-8CEA-31C665072B2CQ35201397-464AB5B1-95D1-4CE4-AA2B-066405E7B0ADQ35201802-65BA1D40-A863-43FE-80B9-06AB6F525CF3Q35252958-4B959C60-70DE-4EC5-937B-C1F1B76E6387Q35684690-A6B4F4B6-F49F-432B-9D52-0CA25D2880A3Q35961413-DF795168-8F5D-46E0-B83A-602173F69918Q36128415-8B26D4D5-1553-4252-A147-30BD5D34AB9FQ36195978-8E675A3B-9728-4764-90F6-62F9FE66FDFBQ36266372-2621A7F1-7EA8-49FD-B990-A812C21C453CQ36285155-36B442ED-D9B8-42E4-A0A4-7DAADAB01634Q36411194-0BFE0987-45F0-4825-BFEC-C061C7FFA850Q36606346-357E07BE-54BD-43BC-90B1-920C422A6614Q36618644-8D48DFEF-DA49-4C1B-913B-A519C8FCC4E0Q36666417-D6EEE8CC-C655-4AE4-BB57-2B7C874BBBBAQ36710074-51290640-4717-42B0-86FE-C4512BCDDE00Q36856813-93357D9F-0E3A-422F-AE7D-AB6607F3F2FFQ36910859-87CB086C-0002-47A3-8CD9-D4DF8CC13087Q36949765-36E4FAE0-B734-42BD-A6AC-31CF95DF79A4Q36987305-A3C57EB0-6263-45CB-8728-1DA616942233Q37118811-4D84B7A7-79E6-476A-AE34-1EF4820D65F8Q37165535-5611F2BD-245D-40CB-954A-DF8FDEC92F76Q37199444-73012B41-2084-4853-86B4-16D6C3F2F2AEQ37238757-07570F90-5EDB-4680-A56F-6DA529C81BD1Q37242277-8B7D7544-516E-4162-962B-6B5F64EBC943Q37639910-103B6C1D-8FB2-4D99-9965-257D47A18C0CQ37864158-00CA2B96-F95A-4DC4-A636-4F4EA324B105Q37913996-612E81D5-98BC-40D2-8906-EBCD5C7196D8Q37974855-B0AD6652-9F0E-4553-8850-371881C9E019Q38021435-F400D93F-82A2-488B-82B7-3C3AED732DC8Q38063535-69C2408A-C7D9-492B-90B8-29E9BB83ECBFQ38224994-7C6688F7-C444-441C-AFB4-C831EA24C5FE
P2860
Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Clinical review 170: A systema ...... differentiated thyroid cancer.
@ast
Clinical review 170: A systema ...... differentiated thyroid cancer.
@en
type
label
Clinical review 170: A systema ...... differentiated thyroid cancer.
@ast
Clinical review 170: A systema ...... differentiated thyroid cancer.
@en
prefLabel
Clinical review 170: A systema ...... differentiated thyroid cancer.
@ast
Clinical review 170: A systema ...... differentiated thyroid cancer.
@en
P2093
P356
P1476
Clinical review 170: A systema ...... differentiated thyroid cancer.
@en
P2093
Anna M Sawka
George Browman
Kullathorn Thephamongkhol
Melissa Brouwers
P304
P356
10.1210/JC.2003-031167
P407
P577
2004-08-01T00:00:00Z